Zakat Eligible: Yes
Location:Saharanpur, U. P.

Hi My name is Suhail Hashmi & I am raising funds for my mother, Mumtaz Begum who is suffering from Breast Cancer 4+ Last Stage & is undergoing treatment at Miras Care (Gurgaon). The family has done all it can to collect the total amount required for the treatment but ₹2 Lakh more reqired for buy 10th Dose.

ROCHE COMPANY - PHESGO (PH-Perjeta + Herceptin; ES-Easy; GO- Go) — a fixed dose combination of two monoclonal antibodies in oncology for the treatment of HER-2 positive breast cancer.

PHESGO is a fixed-dose combination of two monoclonal antibodies – Perjeta (Pertuzumab) & Herceptin (trastuzumab) with hyaluronidase, administered by subcutaneous (under the skin) injection in combination with intravenous (IV) chemotherapy, for the treatment of early & metastatic HER2-positive breast cancer. This is the first time that Roche has combined two monoclonal antibodies that can be administered by a single SC injection.

ROCHE Injection PHESGO Vial 600mg. ₹ 2,30,000 / Per Vial Dose

NARANG BIOTEC PVT LTD. : Address: 3966, 2nd Floor, Roshanara Rd, Arya Pura, Sabzi M&i Old, New Delhi, Delhi 110007

PATIENT SUMMARY

Name of the Patient : Mrs. Mumtaz Begum
Miras Care Gurgaon | UHID : 565
Phone : 9690638030
Sex/Age : Female/48year
Attendent : Suhail Hashmi
Permanent Address : 3/678 Delhi Furniture Street KhanAlampura, Saharanpur, Uttar Pradesh
Consultant : Dr. Mohit Saxena (MBBS, MD, DM – Oncology (Medical Oncologist)

BREAST CANCER 4+ Stage – TREATMENT HISTORY & PROCEDURE DONE

Palliative Therapy : Complete 9 Cycles of Trastuzumab Herclon + Pertuzumab Perjeta + Phesgo

• Injection Trastuzumab Herclon : 7 Doses Complete | ₹54,000 x 7 = ₹3,78,000
• Injection Pertuzumab Perjeta : 7 Doses Complete | ₹2,07,000 x 7 = ₹14,49,000
• Injection Phesgo : 2 Doses Complete | ₹2,30,000 x 2 = ₹4,60,000
• Palliative Brain Radiotherapy – 0-10+ Fractions + All Expenses in ILBS Hospital | ₹2,50,000

Roche Injection Phesgo ₹2,30,000 Vial 600mg - Last 3 Doses are Left





INVESTIGATIONS

• FNAC Left Breast ( J / 2021 / 1766 , 26-09-2021 ) - Invasive ductal ca rcinoma, CODE - V
• PET CT scan whole body ( 22-10-2021 ) - Metabolically active soft tissue lesion involving left breast- primary neoplasm. Metabolically active left axillary , deep pectoral , left supraclavicular & lower cervical lymph nodes & lesions involving liver- Metastasis
• HPE ( 2129675 , 26-10-2021 ) - Invasive Breast Carcinoma , NST , ER- Negative ( 0/8 ) , PR- Negative ( 0/8 ) , Her2Neu Positive ( 3+ ) , Ki67-40 %
• PET CT scan whole body ( 25-05-2022 ) - As compared to previous study dated 22-10-2021 , there is significant interval decrease in in size & metabolic activity of left breast mass & left axillary level I lymph nodal metastases there is complete resolution of left cervical , left axillary level II - III lymph nodes & hypodense lesion in segment V of liver , overall features suggestive of good partial metabolic response
• Brain MRI – Full Brain